-
Overfitting Mitigation in Neural Networks: Could Ergodic Regularization Be the Future of AI?
Sep 9, 2025, 16:22 PM -
Cost-Consequence and Clinical Impact of NGS Testing in Advanced Lung Adenocarcinoma: Real-World Evidence From a Portuguese Public Hospital
Sep 9, 2025, 16:22 PM -
Durable Medical Equipment and Ancillary Service Use in Rett Syndrome Management: A Global Comprehensive Review of Literature
Sep 9, 2025, 16:22 PM -
English Translation, Cross-Cultural Adaptation and Validation of the French New Patient-Reported Outcome Measures of the Multiple Sclerosis Autonomy Scale (MSAS)
Sep 9, 2025, 16:22 PM -
Integrated Sustainability Assessment of the Population-Based Colorectal Cancer Screening Program in Flanders
Sep 9, 2025, 16:22 PM -
Importance of Decisional Context in the Health Technology Assessment (HTA) of Advanced Therapy Medicinal Products (ATMPs)
Sep 9, 2025, 16:22 PM -
Cost-Effectiveness Modeling Based on a Clinical Trial Re-analysis Using Multimodal Machine Artificial Intelligence Methodology: Predicting Which Patients May Benefit Most From the Addition of Tremelimumab to Durvalumab Plus Chemotherapy in First-Line...
Sep 9, 2025, 16:22 PM -
Navigating Three Systems: A Comparative Analysis of Pharmaceutical Reimbursement in Germany, Austria, and Switzerland
Sep 9, 2025, 16:22 PM -
Burden of Disease and Healthcare Resource Use in Patients With Hereditary Transthyretin Amyloidosis in Spain: Findings From the OverTTuRe Global Study
Sep 9, 2025, 16:22 PM -
Impact of Budesonide-Glycopyrronium Formoterol Initiation on Healthcare Resource Utilization and Carbon Emissions in Patients With COPD in Spain: Insights From the ORESTES Study
Sep 9, 2025, 16:22 PM -
Development of a Markov Model-Based Visualization Tool of Regional HPV Vaccination Coverage Rates Over Time in Austria: Combining Data From Pharmaceutical Industry and Healthcare Data Including National Vaccination Registry
Sep 9, 2025, 16:22 PM -
Determinants of Willingness to Pay Thresholds in NICE Oncology Technology Appraisals
Sep 9, 2025, 16:22 PM -
Acceptance of Artificial Intelligence in Evidence and Dossier Development by Global HTA Agencies
Sep 9, 2025, 16:22 PM -
Evolution of Pharmaceutical Pricing and Reimbursement Agreements in Spain Over the Last 10 Years: Towards an Outcomes-Based Approach
Sep 9, 2025, 16:22 PM -
Healthcare Resource Utilization and Economic Burden Among Caregivers of Individuals With Autism Spectrum Disorder Caregiver: Findings From the 2024 5EU National Health and Wellness Survey
Sep 9, 2025, 16:22 PM -
A Review of the UK's International Recognition Procedure and Its Role in Expediting Access to Innovative Treatments
Sep 9, 2025, 16:22 PM -
Advancing the Science of Qualitative Patient Preference Assessment Using Large Language Models
Sep 9, 2025, 16:22 PM -
Development and Assessment of a Portability Strategy for Computable Operational Definitions
Sep 9, 2025, 16:22 PM -
An Exploration of the Incidence Rate of Anxiety and Depression Following a Diagnosis of Osteoarthritis Using the THIN Dataset
Sep 9, 2025, 16:22 PM -
Economic Evaluations of First-Line Non-Small Cell Lung Cancer Therapies: A Systematic Review With Focus on PD-L1 Subgroups
Sep 9, 2025, 16:22 PM